September 2024

Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from over 600,000 United States based patients; approximately one-third are tissue samples.  Ovation plans to continue expanding the biobank with the

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: